| Name | Title | Contact Details |
|---|
We are a global, diversified producer of high technology specialty chemical products and provider of technical services. Our business involves the formulation of a broad range of specialty chemicals created by blending raw materials through multi-step technological processes or formulating active ingredients into final agricultural products, which can be easily and safely used by growers in the field. These specialty chemicals are sold into multiple industries, including agricultural, electronics, graphic arts, metals and plastic plating, and offshore oil production and drilling. We refer to our products as “dynamic chemistries” due to their intricate chemical compositions. Our dynamic chemistries are used in a wide variety of attractive niche markets.
Evan-dow Specialty Chem is a Waterloo, NY-based company in the Manufacturing sector.
Crown Sheet Metal and Skylights is a Brisbane, CA-based company in the Manufacturing sector.
ACME Specialty Chemical is a Notre Dame, IN-based company in the Manufacturing sector.
Verde Science has assembled an impressive team of scientists from highly technical disciplines including Bioprocess Technology, Nanotechnology, Molecular Virology and Immunology, Molecular Biology, Pharmacology and Medical Device Design. Our focus is the discovery of novel drugs and new treatment modalities, as well as cutting edge diagnostic devices and pharmaceutical delivery systems for the treatment of emerging diseases and contemporary medical issues where current treatments either do not exist or are inadequate. Our Research and Development program includes collaboration with our R&D alliance partners which include the Sterkem Group, an integrated pharmaceutical firm based in Mumbai, India; the Institute for Chemical Technology, a Mumbai, India based science and technology university; and our researchers based in India and Canada. We believe that this synergistic and nimble team of highly skilled scientists is the most cost-effective and efficient way to rapidly respond to the increasing array of inadequately addressed contemporary medical issues facing the world community. An initial focus is on developing custom medicinal formulations from cannabinoids and THC compounds for the treatment of specific issues such as migraines, glaucoma, loss of appetite from cancer therapies, and numerous other medical issues. Verde also plans to alpha test innovative growing technologies in India as part of the company’s initiatives.